It Is Impossible to Have a Vaccine by End of Year, Says Dr. Michael Kinch

It Is Impossible to Have a Vaccine by End of Year, Says Dr. Michael Kinch

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Wayground Content

FREE Resource

The transcript discusses the challenges and timelines involved in developing a COVID-19 vaccine, comparing it to historical vaccine developments like polio. It highlights the importance of extensive clinical trials for safety and effectiveness, the role of modern resources and technology, and the potential risks of rushing the process. The discussion also touches on the complexities of the immune system and the evolutionary dynamics of viruses.

Read more

7 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the average time needed to develop a vaccine historically?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What challenges are associated with developing a vaccine in less than four years?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the potential safety risks involved in vaccine development?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

How does the historical context of the polio vaccine relate to current vaccine development?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

What parallels can be drawn between the development of the polio vaccine and the COVID-19 vaccine?

Evaluate responses using AI:

OFF

6.

OPEN ENDED QUESTION

3 mins • 1 pt

What advancements in science today could potentially expedite vaccine development?

Evaluate responses using AI:

OFF

7.

OPEN ENDED QUESTION

3 mins • 1 pt

What complexities are involved in designing a vaccine that engages the immune system without causing toxicity?

Evaluate responses using AI:

OFF